Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
about
Sleep in the Elderly: Burden, Diagnosis, and TreatmentThe effect of IM droperidol on driving performanceDaytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine.Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia.Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers.
P2860
Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Characterization of daytime sl ...... owing H1 receptor antagonists.
@en
Characterization of daytime sl ...... owing H1 receptor antagonists.
@nl
type
label
Characterization of daytime sl ...... owing H1 receptor antagonists.
@en
Characterization of daytime sl ...... owing H1 receptor antagonists.
@nl
prefLabel
Characterization of daytime sl ...... owing H1 receptor antagonists.
@en
Characterization of daytime sl ...... owing H1 receptor antagonists.
@nl
P2093
P1476
Characterization of daytime sl ...... lowing H1 receptor antagonists
@en
P2093
P304
P577
1995-05-01T00:00:00Z